HCA Healthcare, Inc. (HCA) on Decifer

Why it ranks here

• It earns strong returns on the money it puts to work, around 19% and it turns most of its profit into real cash.
• Revenue is growing about 7% a year and profits grew 29% over the past year.
• It keeps a healthy share of every sale as profit, and that has stayed steady over the years, a sign of real pricing power.
• It is riding an active market tailwind and has the balance sheet to fund its growth.
• It is not watering down its owners with new shares and it returns cash to shareholders.

The current read

The evidence on HCA lines up on the supportive side: the intelligence feed flags this name as connected to what is moving markets now. The independent signals we track are telling the same story.

Themes

• Healthcare, Biotech & Devices: HCA Healthcare sits in the care delivery layer of the Healthcare, Biotech & Devices story.
• GLP-1 & Metabolic Health: HCA Healthcare is the largest US for-profit hospital operator with 180+ hospitals and 2,000+ outpatient sites. Reduced obesity-related comorbidities from GLP-1 adoption could lower high-acuity admissions long term, but the transition creates increased outpatient metabolic monitoring demand. HCA benefits from solid same-facility volume growth and its scale advantage in managed care negotiations.

Read the full HCA research brief · See all quality rankings

Intelligence data powered by Decifer. Not financial advice. For informational purposes only.